Moderna CEO: We're preparing our FDA filing for our RSV vaccine Published 2023-01-18 Download video MP4 360p Download video MP4 720p Recommendations 04:24 We've only seen the beginning of Moderna's story, says Goldman Sachs' Salveen Richter 07:00 Moderna CEO on Vaccines, Mutation Risk 08:08 Moderna CEO Stephane Bancel on Q4 results: There is so much more to Moderna than Covid 04:51 Google has proven it's not AI roadkill, says Evercore ISI's Mark Mahaney 06:36 The Einstein Of Wall Street Reveals Successes And Failures As NYSE's Most Famous Trader 02:43 FDA advisers recommend approval of two RSV vaccines 09:41 Moderna, Merck Skin Cancer Vaccine Cuts Risks of Death in Trial 06:46 Moderna CEO discusses earnings and how the company aims to break even by 2026 12:04 Moderna co-founder talks COVID-19 vaccines, mRNA growth, agriculture portfolio 11:12 What Makes New York City More Expensive Than London? 14:55 What's next after the House passed bill outlining a crypto regulatory framework: CNBC Crypto World 02:51 Watch Citadel's high-speed trading in action 05:53 Living On $172K A Year In NYC | Millennial Money 04:31 Raymond James' Sunaina Sinha Haldea: There's more hope on the horizon for dealmaking 14:24 Moderna Vaccine Shows Signs It Can Stop Virus From Replicating, CEO Says 18:14 Why Rent In NYC Is Out Of Control Right Now 20:27 BioNTech, Moderna & CureVac: Neue Entwicklungen bei den mRNA-Aktien! 07:31 Watch what happens once Tesla starts selling cars for $25,000, says billionaire investor Ron Baron 10:06 Moderna will apply ‘same intensity’ for cancer vaccine as it did for COVID, CEO says 05:24 There's room for more than one beneficiary in the AI chips space, says KeyBanc's John Vinh Similar videos 01:37 Moderna CEO: 'Vaccines are one of the best investments we can make' 00:31 Moderna: RSV vaccine about 84% effective at preventing serious illness 07:20 Moderna CEO on combo Covid, flu vaccine moving to next trial phase 08:04 Moderna Focused on Cutting Costs, RSV Vaccine 3:08:50 Moderna Annual R&D Day 2022 03:19 Moderna: RSV vaccine is 84% effective in older adults 2:39:17 Moderna CEO Stéphane Bancel testifies on potential Covid vaccine price hike — 3/22/23 09:22 Moderna CEO Talks New Drugs | Bloomberg Talks 01:04 Moderna says its RSV vaccine highly effective in older adults 00:40 Pfizer Plans To Submit RSV Vaccine For Approval By End Of 2022 08:44 COVID-19 ‘is not leaving the planet,’ Moderna CEO says 13:22 Moderna CEO discusses COVID-19 risks, vaccine boosters, MRNA technology and more 01:40 Moderna's phase three RSV trial found to be 83.7% effective in older adults 06:01 Moderna seeks full FDA approval for its COVID-19 vaccine 15:12 Moderna CEO Stephane Bancel talks business, vaccine demand, and medical advances 00:13 New RSV Vaccine coming soon?! 28:23 Moderna Vaccine Had Decade Head Start Over Pfizer: Chairman More results